Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.

Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, Fukada SY, Liu FT, Liew FY, Lukic ML.

J Immunol. 2009 Jan 15;182(2):1167-73.

2.

Resistance to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by death receptor 6-deficient mice.

Schmidt CS, Zhao J, Chain J, Hepburn D, Gitter B, Sandusky G, Chintalacharuvu S, Glasebrook A, Na S.

J Immunol. 2005 Aug 15;175(4):2286-92.

4.

Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.

Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A.

J Immunol. 2003 Nov 1;171(9):4485-92.

5.

De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.

Tompkins SM, Padilla J, Dal Canto MC, Ting JP, Van Kaer L, Miller SD.

J Immunol. 2002 Apr 15;168(8):4173-83.

7.

IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y.

J Immunol. 2006 Jul 1;177(1):566-73.

10.

CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis.

Teige A, Teige I, Lavasani S, Bockermann R, Mondoc E, Holmdahl R, Issazadeh-Navikas S.

J Immunol. 2004 Jan 1;172(1):186-94.

11.

Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.

Natarajan C, Muthian G, Barak Y, Evans RM, Bright JJ.

J Immunol. 2003 Dec 1;171(11):5743-50. Erratum in: J Immunol. 2004 Apr 15;172(8):following 5127.

12.

MOG extracellular domain (p1-125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE.

Mony JT, Khorooshi R, Owens T.

Mult Scler. 2014 Sep;20(10):1312-21. doi: 10.1177/1352458514524086.

PMID:
24552747
13.

Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.

Eckhardt J, Döbbeler M, König C, Kuczera K, Kuhnt C, Ostalecki C, Zinser E, Mak TW, Steinkasserer A, Lechmann M.

Clin Exp Immunol. 2015 Jul;181(1):51-64. doi: 10.1111/cei.12621.

14.
16.

Suppression of inflammatory responses during myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis is regulated by AKT3 signaling.

Tsiperson V, Gruber RC, Goldberg MF, Jordan A, Weinger JG, Macian F, Shafit-Zagardo B.

J Immunol. 2013 Feb 15;190(4):1528-39. doi: 10.4049/jimmunol.1201387.

18.

Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.

Tan SL, Zhao J, Bi C, Chen XC, Hepburn DL, Wang J, Sedgwick JD, Chintalacharuvu SR, Na S.

J Immunol. 2006 Mar 1;176(5):2872-9.

19.

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.

20.

Supplemental Content

Support Center